Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00764985 · ClinicalTrials.gov registry record

Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis

A clinical trial of Syncope, sponsored by St. Luke's-Roosevelt Hospital Center.

Completed
Registry status
540
Enrollment target
1
Study location

NCT00764985 is a study of Syncope that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 540 participants, below the 802-participant average among 11 other Syncope trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00764985, a study of Syncope, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.

COMPLETED
Registry status
540 participants
Enrollment target
1
Study location

Study Summary

The investigators want to look at how patients admitted after passing out (syncope) or nearly passing out (pre-syncope) do after going home and how many of them remain free of symptoms of syncope or pre-syncope.

Conditions Studied

Study Locations (1)

New York

  • St. Luke's-Roosevelt Hospital Center - New York

Trial Details

FieldValue
Enrollment Target 540 participants
Start Date 2008-06
Est. Completion 2010-07

What the Registry Record Tells You About NCT00764985

The ClinicalTrials.gov registry entry for NCT00764985 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 802-participant average among 11 other Syncope trials with a reported enrollment target (33% lower). The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Syncope appearing as the primary indexed condition, and to 0 interventions.

NCT00764985 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00764985 about?

NCT00764985 is a clinical study titled "Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis". The investigators want to look at how patients admitted after passing out (syncope) or nearly passing out (pre-syncope) do after going home and how many of them remain free of symptoms of syncope or pre-syncope.

What is the current status of trial NCT00764985?

This trial is currently completed. The enrollment target is 540 participants. The study started on 2008-06. Estimated completion is 2010-07.

What conditions does trial NCT00764985 study?

This clinical trial studies the following conditions: Syncope.

Who is sponsoring clinical trial NCT00764985?

This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00764985 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Syncope

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.